Lexicon Pharmaceuticals Inc. (LXRX) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Lexicon Pharmaceuticals I...

    NASDAQ: LXRX · Real-Time Price · USD
    1.40
    0.06 (4.48%)
    At close: Sep 26, 2025, 3:59 PM
    1.39
    -0.71%
    After-hours: Sep 26, 2025, 07:30 PM EDT

    Lexicon Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 66.66M 22.46M 46.34M 64.06M
    Short-Term Investments
    		 171.3M 147.56M 92.01M 22.68M
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 368K 828K 412K 2.27M
    Receivables
    		 3.47M 1.01M 28K 14K
    Inventory
    		 231K 381K n/a n/a
    Other Current Assets
    		 4.53M 5.13M 2.48M 2.16M
    Total Current Assets
    		 246.19M 176.55M 140.87M 88.92M
    Property-Plant & Equipment
    		 7.32M 7.51M 8.48M 1.18M
    Goodwill & Intangibles
    		 44.54M 44.54M 44.54M 44.54M
    Total Long-Term Assets
    		 52.23M 52.88M 53.43M 47.99M
    Total Assets
    		 298.42M 229.43M 194.3M 136.91M
    Account Payables
    		 14.8M 14.39M 10.39M 9.15M
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 n/a n/a n/a n/a
    Other Current Liabilities
    		 14.71M 9.59M 3.66M n/a
    Total Current Liabilities
    		 45.25M 31.55M 23.17M 22.12M
    Long-Term Debt
    		 100.3M 99.51M 48.58M n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 107.22M 104.77M 54M 1.19M
    Total Liabilities
    		 152.47M 136.32M 77.17M 23.31M
    Total Debt
    		 108.4M 106.06M 55.29M 2.28M
    Book Value
    		 145.95M 93.11M 117.12M 113.59M
    Book Value Per Share
    		 0.46 0.42 0.71 0.78
    Common Stock
    		 363K 245K 189K 150K
    Retained Earnings
    		 -1.97B -1.77B -1.59B -1.49B
    Comprehensive Income
    		 119K 31K -428K -10K
    Shareholders Equity
    		 145.95M 93.11M 117.12M -1.49B
    Total Investments
    		 171.3M 147.56M 92.01M 22.68M

    Add to Watchlist